Thank you to all who joined us live for PrimaryCareNOW on Thursday–Saturday, September 10–12, 2020. If you were not able to join us, most sessions have been recorded and are available below.

Upcoming Virtual Conferences
Pri-Med has more virtual education planned. View our upcoming virtual conference schedule.

Upcoming Conferences


Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8-9am ET

Keynote Address

25 Years of Medicine: A Look at the Past, Present, and the Future 

Sanjiv Chopra, MD, MACP | Frank J. Domino, MD

 

During this session, Dr. Chopra and Dr. Domino will review the recent evolution of medicine, highlighting the most significant innovations that have taken place in clinical medicine over the past 25 years and discussing the potential changes to come in the next 25 years.

Sanjiv Chopra, MD, MACP 

Sanjiv Chopra, MD, MACP

Professor of Medicine, Harvard Medical School; Marshal Wolf Master Clinician Educator, Brigham and Women's Hospital, Boston, MA

Frank J. Domino, MD 

Frank J. Domino, MD

Professor, Family Medicine and Community Health University of Massachusetts Medical School, Worcester, MA

9:10–10:10am ET

Infectious Disease

Managing Influenza: Practical Strategies For Primary Care 

Kalpana Gupta, MD, MPH | Pamela Kushner, MD, FAAFP


 

Is influenza going viral in your practice? This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.

Kalpana Gupta, MD, MPH 

Kalpana Gupta, MD, MPH

Chief of Infectious Diseases, VA Boston Healthcare System; Professor of Medicine, Boston University School of Medicine, Boston, MA

Pamela Kushner, MD, FAAFP 

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center; Director, Kushner Wellness Center, Los Alamitos, CA

This session is supported by an independent educational grant from Genentech, a member of the Roche Group

10:20–11:05am ET

Industry Theater

Know When Eosinophils Play a Role in Severe Asthma 

Jonathan Corren, MD

 

Join us for an educational program exploring the role of eosinophils in severe asthma. This presentation will examine key concepts in severe asthma, including, defining severe uncontrolled asthma and the impact of oral corticosteroid (OCS) use in severe uncontrolled asthma.

Jonathan Corren, MD 

Jonathan Corren, MD

Department of Medicine and Pediatrics, Division of Allergy and Clinical Immunology, David Geffen School of Medicine at University of California Los Angeles

Sponsored by AstraZeneca

11:15am–12:15pm ET

Endocrinology

Highs & Lows: Opportunities and Benefits of Continuous Glucose Monitoring in Primary Care 

Martin J. Abrahamson, MD, FACP | Patricia H. Montesinos, MSN


 

Continuous glucose monitoring (CGM) is at the forefront of new diabetes technologies and can lead to improved care for many people with Type I and Type II Diabetes. However, the expanding diabetes market challenges primary care clinicians to keep up with guidelines on how and when to use personal and professional CGM devices. This session, developed in partnership with the Association of Diabetes Care and Education Specialists (ADCES), will educate clinicians on how to identify people who are candidates for CGM, interpret CGM data, and adjust treatment plans, while effectively involving patients in these decisions. These practical strategies and insights for using CGM will help transform this new technology from a specialty-based tool to an integral part of diabetes management in the primary care setting.

Martin J. Abrahamson, MD, FACP 

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine, Harvard Medical School; Director, Division of CME, Beth Israel Medical Center, Beth Israel Deaconess Medical Center, Boston, MA

Patricia H. Montesinos, MSN 

Patricia H. Montesinos, MSN

MedStar Diabetes Institute, Washington, DC

Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

12:25–1:25pm ET

Neurology

What a Headache! New Approaches to Chronic Migraine Management 

M. Susan Burke, MD, FACP | Rashmi B. Halker Singh, MD, FAHS, FAAN


 

Watch expert faculty discuss assess and treat migraine through the case of a young man with recurrent headaches. Treatment will focus on traditional and new preventive therapies for chronic migraine as well as patient self-management strategies to optimize management.

This session is designed to satisfy CME/CE requirements on Pain Management. Please check with your state licensing board for their specific requirements.

M. Susan Burke, MD, FACP 

M. Susan Burke, MD, FACP

Clinical Associate Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Senior Advisor, Lankenau Medical Associates, Lankenau Medical Center, Wynnewood, PA

Rashmi B. Halker Singh, MD, FAHS, FAAN 

Rashmi B. Halker Singh, MD, FAHS, FAAN

Headache Fellowship Program Director, Associate Professor of Neurology, Mayo Clinic, Scottsdale, AZ

Supported by Teva Pharmaceuticals

1:35–2:20pm ET

Industry Theater

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain 

Dr. Jason Faller

 

1) Understand the causes and prevalence of chronic low back pain
2) Differentiate inflammatory back pain (IBP) from mechanical back pain
3) Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS)
4) Learn the importance of referring patients with IBP to a rheumatologist in a timely manner

Dr. Jason Faller  

Dr. Jason Faller

Sponsored by AbbVie

2:30–4pm ET

Cardiology

Cardiology Updates: Hypertension and Management of Heart Failure 

Jon A. Kobashigawa, MD | Karol E. Watson, MD, PhD


 

Heart failure (HF) affects more than 6 million Americans with approximately 50% mortality at 5 years. This session will show how recent advances in heart failure treatment have contributed to improved survival. This session will also discuss the guidelines, supporting evidence, and interventions to maximize hypertension management for individual patients.

Jon A. Kobashigawa, MD 

Jon A. Kobashigawa, MD

DSL/Thomas D. Gordon Professor of Medicine; Associate Director, Cedars-Sinai Smidt Heart Institute; Director, Advanced Heart Disease Section, Director, Heart Transplant Program, Cedars-Sinai Medical Center, Los Angeles, California

Karol E. Watson, MD, PhD 

Karol E. Watson, MD, PhD

Professor of Medicine/Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Co-director, UCLA Program in Preventive Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA, Los Angeles, CA

4:10–5:10pm ET

Practice Management


 

Social technologies, such as social media and wearable devices, are increasingly prevalent in society. These technologies, and their data, can be used to help inform public health and medicine. For example, online communities can be developed and used in ways to positively change patient behaviors; data from these and other technologies can be used to monitor and predict public health outcomes, such as disease outbreaks. This talk will discuss research in these areas and how technologies can be used to predict and change health behaviors and outcomes.

Sean D. Young, PhD, MS 

Sean D. Young, PhD, MS

Executive Director, Institute for Prediction Technology, Associate Professor, UC Irvine Emergency Medicine and Informatics

5:20–6:05pm ET

Industry Theater

Is It Time to Reconsider Your Treatment Strategy in Your Patients With T2D? 

Nathaniel G. Clark, MD, MS, RD

 

Explore efficacy and safety data for 2 GLP-1 RA options for adults with T2D. A data review from pivotal glycemic control trials as well as cardiovascular outcomes data will be presented.

Nathaniel G. Clark, MD, MS, RD 

Nathaniel G. Clark, MD, MS, RD

Endocrinologist, Beth Israel Deaconess Hospital – Plymouth, Plymouth & Sandwich, Massachusetts

Sponsored by Novo Nordisk

6:15–7:15pm ET

Oncology

Cancer Survivorship: An Update 

Patricia A. Ganz, MD


 

This presentation will provide background on the epidemiology of cancer survivorship and focus on the growing numbers of individuals with a history of cancer who are in primary care clinical practice. Dr. Ganz will discuss the common long-term and late effects of cancer treatment and what kind of follow-up care patients need, including the important role primary care providers (PCPs) can play in health promotion and disease prevention. The talk will emphasize the importance of collaboration between oncologists and PCPs in the follow-up care of cancer survivors.

Patricia A. Ganz, MD 

Patricia A. Ganz, MD

Distinguished Professor, UCLA School of Medicine and Public Health, Los Angeles, CA

8–11:30am ET

Pain Management

Strategies for Effective Pain Management

Charles E. Argoff, MD, FABPM | Katherine E. Galluzzi, DO, CMD, FACOFP | Oscar A. de Leon-Casasola, MD


 

The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain versus the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse to manage patients’ pain and medication use optimally.

This session is designed to satisfy CME/CE requirements on Pain Management. Please check with your state licensing board for their specific requirements. Participate in this Opioid Analgesic REMS activity to earn 3.5 Medical Knowledge and Patient Safety Points in the ABIM MOC program.

Charles E. Argoff, MD, FABPM 

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College; Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD 

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair; The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Katherine E. Galluzzi, DO, CMD, FACOFP 

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Opioid Analgesic REMS Program Companies

11:40am–12:25pm ET

Industry Theater

COPD: Simplifying a Complex Paradigm for Busy Clinicians 

Neil Skolnik, MD

This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.

Neil Skolnik, MD

Neil Skolnik, MD

Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Sponsored by GlaxoSmithKline

11:40am–12:25pm ET

Industry Theater

Close to the Heart: The Importance of Recognizing Cardiovascular Risk in Type 2 Diabetes 

Eugene E. Wright, Jr. MD

 

The objective of this program is to communicate the importance of addressing cardiovascular risk in patients with type 2 diabetes. The program will cover data on prevalence, morbidity, mortality, and intensive versus conventional glucose lowering on macrovascular complications. In addition, the program will review guidance from leading medical associations that is based upon completed cardiovascular outcome trials of antihyperglycemic medications in patients with type 2 diabetes.

Eugene E. Wright, Jr. MD 

Eugene E. Wright, Jr. MD

Medical Director, Performance Improvement, Charlotte Area Health Education Center (AHEC), Charlotte, NC; Consulting Associate, Department of Medicine, Duke University Medical Center, Durham, NC

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

12:35–1:35pm ET

Psychiatry


 

In this presentation, Dr. Vollmer will review the various pharmacological and non-pharmacological tools which can help the anxious patient. There will be a brief overview of diagnostic categories of anxiety disorders followed by treatment interventions and long-term management suggestions.

Shirah Vollmer, MD 

Shirah Vollmer, MD

Clinical Professor of Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA

1:45–2:30pm ET

Industry Theater

Uncontrolled Asthma: Changing the Patient Experience 

Matthew Mintz, MD

 

In this session, Dr. Mintz will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.

Matthew Mintz, MD 

Matthew Mintz, MD

Associate Clinical Professor of Medicine at George Washington University School of Medicine & Health Sciences; Internal Medicine and Primary Care Physician, Private Practice in Bethesda, Maryland

Sponsored by GlaxoSmithKline

2:40–3:40pm ET

Cardiology

Clinical Considerations on Lipid Management of ASCVD in the New Era 

Sergio Fazio, MD, PhD | Karol E. Watson, MD, PhD, FACC


 

Providing practical information in an informative format focused on lipid management of ASCVD in the New Era, learners will be provided with important changes in ASCVD guidelines, recognition of elevated triglyceride levels as a target for therapy, a review of clinical trials that recently made a difference in lipid management, practical considerations on using lipid-modifying therapies, and the latest on omega-3 fatty acids for ASCVD.

Sergio Fazio, MD, PhD 

Sergio Fazio, MD, PhD

Professor of Medicine, Director of Preventive Cardiology, Oregon Health & Science University, Portland, OR

Karol E. Watson, MD, PhD, FACC 

Karol E. Watson, MD, PhD, FACC

Professor of Medicine/Cardiology, Co-director, UCLA Program in Preventive Cardiology, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA, Los Angeles, CA

Supported by Amarin Pharma Inc.

3:50–4:50pm ET

Infectious Disease

COVID-19 Panel Discussion 

Ty J. Gluckman, MD, FACC, FAHA | Paul E. Sax, MD | Charles Vega, MD, FAAFP


 

These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care, cardiology, and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.

Ty J. Gluckman, MD, FACC, FAHA 

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

Paul E. Sax, MD 

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School, Boston, MA

Charles Vega, MD, FAAFP 

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine Irvine, CA

5–5:45pm ET

Industry Theater

 

This program will highlight a different approach to the treatment of heart failure with reduced ejection fraction (HFrEF). By targeting a mechanism of action aligned to pathophysiologic pathways, it is possible to reduce patient mortality and morbidity, while providing a proven safety and tolerability profile to help provide confidence in selecting your first-choice therapy for patients with HFrEF.

Javed Butler, MD, MPH, MBA 

Javed Butler, MD, MPH, MBA

Chairman and Professor, Department of Medicine, University of Mississippi, Jackson, MS

Sponsored by Novartis Pharmaceuticals Corporation

8–9am ET

Keynote Address

Eat, Drink, Pray! Foodborne Infections, Old and New 

Claire Panosian Dunavan, MD, DTM&H

 

Every year, one in ten people worldwide experience a foodborne infection caused by a broad range of pathogens, from common enteric viruses and bacteria to less familiar parasites. There are many factors influencing the modern burden of foodborne illness: our increasingly global food supply, the ongoing changes in food production, consumer tastes, and food safety practices, the growing number of vulnerable and/or immunosuppressed hosts, and even climate change. This talk will summarize the modern ecology of foodborne disease, describe the clinical presentation of common foodborne pathogens, and update you several foodborne parasites currently emerging in the United States.

Claire Panosian Dunavan, MD, DTM&H  

Claire Panosian Dunavan, MD, DTM&H (London)

Clinical Professor of Medicine Emeritus/Recalled, Division of Inectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA

9:10–10:10am ET

Neurology

Heading Forward: Adapting New Data on Headache Disorders to Clinical Practice

Shirely Kessel, BS | Amaal J. Starling, MD | Jeff Unger, MD, FAAFP, FACE

 

This program addresses the challenges of diagnosing and treating primary headache disorders in the time of COVID-19, including factors like social distancing and maintaining patient adherence. The discussion will feature a patient with chronic migraine, along with two medical experts–a headache specialist and a primary care physician–who will differentiate burden and presentation between migraine and cluster headaches. A particular focus will be on individualizing treatment paradigms for patients with migraine disorders.

Shirely Kessel, BS 

Shirely Kessel, BS

Executive Director, Miles for Migraine, Lafayette Hill, PA

Amaal J. Starling, MD  

Amaal J. Starling, MD

Assistant Professor of Neurology, Mayo Clinic College of Medicine and Science, Scottsdale, AZ

Jeff Unger, MD, FAAFP, FACE 

Jeff Unger, MD, FAAFP, FACE

Director, Unger Primary Care Concierge Medical Group, Rancho Cucamonga, CA

Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

10:20–11:05am ET

Industry Theater

The Burden and Management of Moderate-to-Severe Atopic Dermatitis in Appropriate Patients 

Elizabeth A. Kiracofe, MD | Elizabeth (Lisa) Swanson, MD

 

Sponsored by Regeneron and Sanofi Genzyme

10:20–11:05am ET

Industry Theater

 

This program will examine the risk factors associated with COPD exacerbations and the potential impacts of acute exacerbations on patient health, quality of life, and mortality. An understanding of COPD exacerbations and the range of consequences highlights opportunities to optimize COPD management earlier in the course of disease.

Dr. Sanjay Sethi, MD 

Dr. Sanjay Sethi, MD

Professor and Chief, Pulmonary, Critical Care and Sleep Medicine; Assistant Vice President for Health Sciences, Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo

Sponsored by AstraZeneca

11:15am–12:15pm ET

Dermatology


 

There have been many recent advances in the medical management of dermatologic disease. This session will cover the diagnosis and management of common skin disorders and provide an update on diagnosis and therapeutics.

Jennifer Haley, MD 

Jennifer Haley, MD

Associate Clinical Professor of Medicine/Dermatology, David Geffen School of Medicine at UCLA; Dermatologist and Dermatopathologist, Southern California Permanete Medical Group, Los Angeles, CA

12:25–1:25pm ET

Endocrinology


 

Adults with type 2 diabetes mellitus (T2DM) have a two- to four-fold increase in risk for cardiovascular (CV) morbidity and mortality. This session cuts to the heart of primary and secondary prevention in this population, presenting recent data on antihyperglycemic medications with proven cardiovascular benefit in the context of updated management algorithms. Individualized treatment is critical to the success of these treatment plans. The faculty will help you optimize adherence through shared decision-making tactics that account for CV risk factors, comorbidities, and patient preferences.

Rachel Bond, MD, FACC 

Rachel Bond, MD, FACC

System Director, Women’s Heart Health, Dignity Health, Arizona, Chandler, AZ

Charles Vega, MD, FAAFP 

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine Irvine, CA

Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

1:35–2:20pm ET

Industry Theater

Expert Perspectives: A New Treatment Option for Adult Patients with Insomnia 

Damon Raskin, MD

 

Are your patients struggling with insomnia? Learn about its prevalence and impact, and an exciting, new treatment option for your patients

Damon Raskin, MD  

Damon Raskin, MD

Physician in Private Practice, Pacific Palisades, CA

Sponsored by Eisai

1:35–2:20pm ET

Industry Theater

FDA-Approved Label Expansion: Progress Your Topical Patients to the Next Step: An Oral Treatment With Data for Moderate to Severe Scalp Psoriasis  

Jennifer Cather, MD, FAAD

 

Dr. Jennifer Cather will be presenting a current oral, non-biologic treatment option in moderate to severe plaque psoriasis.

Jennifer Cather, MD, FAAD 

Jennifer Cather, MD, FAAD

Sponsored by Amgen Inc.

2:30–3:30pm ET

Hot Topic


 

In order to provide high-quality, effective care to individuals of different backgrounds, it is essential to respond to patients’ culture and values. In this session with Dr. Charles Vega, we will explore ways to improve the care of your Latino patients. Dr. Vega will discuss common health beliefs among Latinos that might their approach to health and illness, as well as explore the health disparities which impact the Latino population.

Charles Vega, MD, FAAFP 

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine Irvine, CA

3:40–4:40pm ET

Wellness

Challenges and Controversies in Diets for Weight Loss 

David Heber, MD, PhD | Zhaoping Li, MD, PhD


 

Nutrition is essential to the prevention and treatment of chronic diseases. In this panel based discussion, the roles of diets and their limitations in clinical practice will be reviewed based on scientific evidence. You will learn about how individual responses and personalized meal plans are the key to success.

David Heber, MD, PhD 

David Heber, MD, PhD

Founding Director, UCLA Center for Human Nutrition; Founding Director, Risk Factor Obesity Program (RFO); Professor Emeritus of Medicine and Public Heath, David Geffen School of Medicine at UCLA, Los Angeles, CA

Zhaoping Li, MD, PhD 

Zhaoping Li, MD, PhD

Center Director and Division Chief, Clinical Nutrition, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

4:50–5:35pm ET

Industry Theater

An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C 

Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC

 

The session will cover the following information:
• Cardiovascular disease and its mortality and morbidity
• Unique mechanism of action for two treatment options
• Efficacy data for two treatment options
• Safety data for two treatment options
• Overview of the ongoing Outcomes trial

Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC 

Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC

Professor and Director, Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine; Past President, American Society for Preventive Cardiology; Past President, Pacific Lipid Association Chapter of the NLA

Sponsored by Esperion Therapeutics


CME/CE Faculty

Martin J. Abrahamson, MD, FACP
Martin J. Abrahamson, MD, FACP
Charles E. Argoff, MD, FABPM
Charles E. Argoff, MD, FABPM
Rachel Bond, MD, FACC
Rachel Bond, MD, FACC
M. Susan Burke, MD, FACP
M. Susan Burke, MD, FACP
Sanjiv Chopra, MD, MACP
Sanjiv Chopra, MD, MACP
Oscar A. de Leon-Casasola, MD
Oscar A. de Leon-Casasola, MD
Frank J. Domino, MD
Frank J. Domino, MD
Sergio Fazio, MD, PhD
Sergio Fazio, MD, PhD
Katherine E. Galluzzi, DO, CMD, FACOFP
Katherine E. Galluzzi, DO, CMD, FACOFP
Patricia A. Ganz, MD
Patricia A. Ganz, MD
Ty J. Gluckman, MD, FACC, FAHA
Ty J. Gluckman, MD, FACC, FAHA
Kalpana Gupta, MD, MPH
Kalpana Gupta, MD, MPH
Jennifer Haley, MD
Jennifer Haley, MD
Rashmi B. Halker Singh, MD, FAHS, FAAN 
Rashmi B. Halker Singh, MD, FAHS, FAAN
David Heber, MD, PhD
David Heber, MD, PhD
Shirely Kessel, BS
Shirely Kessel, BS
Jon A. Kobashigawa, MD
Jon A. Kobashigawa, MD
Pamela Kushner, MD, FAAFP
Pamela Kushner, MD, FAAFP
Zhaoping Li, MD, PhD
Zhaoping Li, MD, PhD
Patricia H. Montesinos, MSN
Patricia H. Montesinos, MSN
Claire Panosian Dunavan, MD, DTM&H
Claire Panosian Dunavan, MD, DTM&H
Martin A. Quan, MD
Martin A. Quan, MD
Paul E. Sax, MD
Paul E. Sax, MD
Amaal J. Starling, MD
Amaal J. Starling, MD
Jeff Unger, MD, FAAFP, FACE
Jeff Unger, MD, FAAFP, FACE
Charles Vega, MD, FAAFP
Charles Vega, MD, FAAFP
Shirah Vollmer, MD
Shirah Vollmer, MD
Karol E. Watson, MD, PhD
Karol E. Watson, MD, PhD
Sean D. Young, PhD, MS
Sean D. Young, PhD, MS